<DOC>
	<DOCNO>NCT02135107</DOCNO>
	<brief_summary>The purpose study assess efficacy safety E3810 10mg twice daily maintenance therapy PPI resistant gastroesophageal reflux disease patient .</brief_summary>
	<brief_title>A Double-blind Comparative Study Efficacy Safety E3810 10mg Once Twice Daily Maintenance Therapy PPI Resistant Gastroesophageal Reflux Disease Patients</brief_title>
	<detailed_description>This randomize , multicenter , parallel-group , double-blind trial investigates efficacy safety E3810 10mg twice daily period 52 week . The non-recurrence rate endoscopically confirm 52 week shall primary end point , shall examine randomize , multicenter , parallel-group , double-blind trial investigates efficacy safety E3810 10mg twice daily period 52 week .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Subjects fulfil criterion shall eligible study : 1 . Patients diagnose gastroesophageal reflux disease show endoscopic examination mucosal lesion ( erosion , ulcer ) 2 . Patients show endoscopy recover despite administration PPI daily eight week . 3 . Patients 20 year age freely give informed consent write participation study . 4 . Patients , receive full explanation matter must adhere study , intend adhere requirement , capable . Subjects fulfil follow criterion shall exclude study : 1 . Patients consider candidate surgical treatment upper gastrointestinal tract due perforation , esophageal stricture , pyloric stenosis , esophageal varix , etc . 2 . Patients ZollingerEllison syndrome . 3 . Patients gastrointestinal hemorrhage . 4 . Patients serious cardiovascular disease , cerebrovascular disease , hematological disorder , renal disease , liver disease , malignant tumor , etc . 5 . Patients long segment Barrett 's esophagus . 6 . Patients open gastric duodenal ulcer . 7 . Patients drug allergy past history drug allergy PPI . 8 . Patients take drug development , do within 12 week prior enrollment . 9 . Patients , may pregnant , patient wish become pregnant study period , patient breastfeed , patient partner wish use reliable contraceptive measure . 10 . Patients history dependence abuse drug alcohol within past two year . 11 . Other patient deem unsuitable inclusion study principal investigator subinvestigators .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Gastroesophageal reflux disease</keyword>
</DOC>